These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2302714)

  • 1. Differential cytotoxicity of diaziquone toward Chinese hamster ovary cells under hypoxic and aerobic exposure conditions.
    O'Brien PJ; Kaul HK; Rauth AM
    Cancer Res; 1990 Mar; 50(5):1516-20. PubMed ID: 2302714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diaziquone-induced cytotoxicity in isolated rat hepatocytes.
    Silva JM; O'Brien PJ
    Cancer Res; 1989 Oct; 49(20):5550-4. PubMed ID: 2790779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.
    Siegel D; Gibson NW; Preusch PC; Ross D
    Cancer Res; 1990 Nov; 50(22):7293-300. PubMed ID: 2121335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial toxicity of 2,5-diaziridinyl-3,6-bis-(carboethoxyamino)-1,4-benzoquinone.
    Oberc-Greenwood MA; Smith BH; Cooke C; Ellis JR; Kornblith PL; McKeever PE
    J Natl Cancer Inst; 1983 Oct; 71(4):725-33. PubMed ID: 6578368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of DNA strand breaks and cross-links by 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone in Chinese hamster ovary cells.
    King CL; Hittelman WN; Loo TL
    Cancer Res; 1984 Dec; 44(12 Pt 1):5634-7. PubMed ID: 6498824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.
    Szmigiero L; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4453-7. PubMed ID: 6467205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
    Fracasso PM; Sartorelli AC
    Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone.
    Ngo EO; Nutter LM; Sura T; Gutierrez PL
    Chem Res Toxicol; 1998 Apr; 11(4):360-8. PubMed ID: 9548807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen and exposure kinetics as factors influencing the cytotoxicity of porfiromycin, a mitomycin C analogue, in Chinese hamster ovary cells.
    Marshall RS; Rauth AM
    Cancer Res; 1988 Oct; 48(20):5655-9. PubMed ID: 3167822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing.
    Szmigiero L; Erickson LC; Ewig RA; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4447-52. PubMed ID: 6467204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of diaziquone free radicals on the in vitro activity of diaziquone.
    Nguyen B; Biswal S; Gutierrez PL
    Xenobiotica; 1988 May; 18(5):593-602. PubMed ID: 2840783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).
    King CL; Wong SK; Loo TL
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):261-4. PubMed ID: 6538490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
    Beall HD; Mulcahy RT; Siegel D; Traver RD; Gibson NW; Ross D
    Cancer Res; 1994 Jun; 54(12):3196-201. PubMed ID: 8205540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986).
    Egorin MJ; Fox BM; Spiegel JF; Gutierrez PL; Friedman RD; Bachur NR
    Cancer Res; 1985 Mar; 45(3):992-9. PubMed ID: 3971389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
    Qiu XB; Cadenas E
    Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant.
    Marshall RS; Rauth AM
    Cancer Res; 1986 Jun; 46(6):2709-13. PubMed ID: 3084075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
    J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of deficiencies in DNA repair on the toxicity of mitomycin C and porfiromycin to CHO cells under aerobic and hypoxic conditions.
    Hughes CS; Irvin CG; Rockwell S
    Cancer Commun; 1991 Feb; 3(2):29-35. PubMed ID: 1899798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.